ciprofloxacin and penicillanic acid

ciprofloxacin has been researched along with penicillanic acid in 83 studies

Research

Studies (83)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	16 (19.28)	18.2507
2000's	23 (27.71)	29.6817
2010's	44 (53.01)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aldridge, KE; Barry, AL; Gelfand, MS; Jones, RN	1
Blakemore, PH; Drabu, YJ; Mehtar, S	1
Hyatt, JM; Nix, DE; Schentag, JJ; Stratton, CW	1
Cantrell, HF; Lankford, RB; Murray, PR	1
Appelbaum, PC; Jacobs, MR; Spangler, SK	2
Arpi, M; Bruun, B; Gottschau, A; Mortensen, I; Victor, MA	1
Bowker, KE; Hedges, AJ; Holt, HA; MacGowan, AP; Reeves, DS; Wootton, M	1
Knapp, CC; Ludwig, MD; Pohlman, JK; Washington, JA	1
Gould, IM; Milne, K	1
Falagas, ME; McDermott, L; Snydman, DR	1
Constantoulaki, S; Paniara, O; Platsouka, E; Zissis, NP	1
Adhikari, M; Pillay, DG; Pillay, T; Sturm, AW	1
Andremont, A; Guy, H; Marie, JP; Pico, JL; Richet, H; Vekhoff, A	1
Babini, GS; Bates, J; Livermore, DM; Palepou, MF; Woodford, N	1
Forrest, A; Nix, DE; Schentag, JJ; Strenkoski-Nix, LC	1
Buchman, TG; Cheadle, WG; Cohn, SM; Haverstock, DC; Jungerwirth, S; Kowalsky, SF; Lipsett, PA; Milsom, JW; O'Marro, S; Rochefort, EV; Yellin, AE	1
Burgess, DS; Hastings, RW	1
Adinolfi, LE; Andreana, A; Casillo, R; Durante Mangoni, E; Farina, C; Gambardella, M; Sarnataro, G; Tripodi, MF; Utili, R	1
Jones, RN; Mutnick, AH; Turner, PJ	1
Evans, ME	1
Burgess, DS; Nathisuwan, S	1
Berardi, B; Callea, A; Cormio, L; Fiorentino, N; Sblendorio, D; Traficante, A; Zizzi, V	1
Finsterer, J; Kotzailias, N	1
Burroughs, A; Fisher, N; Hastings, M; Kibbler, C; Mutimer, D; O'Grady, J; Patch, D; Philpott-Howard, J; Rolando, N; Wade, J; Wendon, J	1
Evangelista, AT; Jones, ME; Karlowsky, JA; Sahm, DF; Thornsberry, C; Yee, YC	1
Jakoniuk, P; Leszczyńska, K; Sacha, PT; Wieczorek, P; Zalewska, M	1
Ashkenazi, S; Bishara, J; Lev, B; Levy, I; Livne, G; Ofir, O; Pitlik, S; Samra, Z	1
Pang, XY; Tian, BW; Yang, YJ	1
Kuti, JL; Nicolau, DP; Sun, HK	1
Bassoul, B; Causse, L; Dareau, S; Delire, V; Eledjam, JJ; Gros, T; Javitary, W	1
Mannaerts, L; Van der Wurff, AA; Wolfhagen, FH	1
Hashikita, G; Kawakami, S; Kobayashi, S; Maesaki, S; Nagasawa, M; Okabe, T; Sasaki, K; Shibuya, S; Suzuki, N; Takayama, S; Uchida, T; Watanabe, M; Yamaguchi, T	1
Bardenstein, R; Carmeli, Y; Chmelnitsky, I; Goland, S; Hammer Muntz, O; Navon Venezia, S; Zimhony, O	1
Bennett, KM; Dodds-Ashley, E; Hayward, TZ; Kaye, KS; Scarborough, JE; Sharpe, M; Vaslef, SN	1
Adelman, MH; Cohn, SM; Gilliland-Johnson, KK; Paladino, JA	1
Aldeyab, MA; Bailie, R; Elshibly, SM; Hanley, J; Hughes, CM; Kearney, MP; McDowell, DA; McElnay, JC; McMahon, MA; Scott, MG	1
Cho, YB; Choi, CH; Jang, CH; Park, H; Park, IY	1
Aldeyab, MA; Hanley, J; Kearney, MP; McElnay, JC; Scott, MG	1
Dundar, D; Otkun, M	1
Flamm, R; Friedland, I; Kaniga, K; Lee, M; Redman, R; Tong, SY	1
Best, L; Boonlayangoor, S; Hebert, C; Lin, M; Pitrak, D; Tolentino, J; Villaran, R; Weber, SG	1
Chien, CC; Lee, CH; Li, CC; Liu, JW; Su, LH; Tang, YF	1
Luetzke, A; Ruebben, H; Schenck, M; Schneider, T	1
Barshikar, S; Baylor, AE; Dolman, HS; Glowniak, J; Hong, K; Lavery, T; Nailor, M; Singla, R; Stassinopoulus, J; Tyburski, JG; Wilson, RF; Zimmerman, LH	1
Blahut, L; Hricová, K; Kolár, M; Neiser, J; Urbánek, K; Uvízl, R; Vojtová, V	1
Amer, MZ; Bandey, M; Bukhari, A; Nemenqani, D	1
Bak, N; Holds, JM; Papanicolas, LE	1
Holodniy, M; Lucero, CA; Mercier, RC; Nguyen, N; Oda, G; Ryono, RA; Schirmer, PL	1
Bellomo, R; Cole, L; Lipman, J; Liu, X; Nair, P; Roberts, DM; Roberts, JA; Roberts, MS	1
Hansson, J; Johnsson, E; Jönsson, C; Körner, U; Ludwigs, K; Lundholm, K	1
Andersson, RE; Schein, M	1
Ansaloni, L; Campanati, L; Catena, F; Coccolini, F; Colaianni, N; Magnone, S; Pisano, M	1
Aziz, MN; Desa, MN; Idris, SN; Taib, NM	1
Garg, PK; Mohanty, D	1
Bonten, MJ; Bootsma, MC; Campbell, J; Chau, NV; Farrar, J; Hoa, NT; Hoang, NV; Loan, HT; Nga, TT; Schultsz, C; Thao, le TP; Thuy, TT; Vien, le M; Wit, F; Yen, LM	1
Akashi, K; Chong, Y; Ito, Y; Kamimura, T; Miyamoto, T; Shimoda, S; Shimono, N; Yakushiji, H	1
Belghiti, J; Bert, F; Dondero, F; Durand, F; Larroque, B; Moreau, R; Nicolas-Chanoine, MH; Paugam-Burtz, C	1
Fortier, LC; Garneau, JR; Valiquette, L	1
Chu, X; Guo, YY; Liu, QZ; Shen, LM; Wang, J; Zhang, CL	1
Frey, L; Maier, B; Suhr, A; Teupser, D; Vogeser, M; Zander, J; Zoller, M	1
Andersen, MH; Arendrup, MC; Bestle, MH; Cozzi-Lepri, A; Drenck, NE; Grarup, J; Hein, L; Helweg-Larsen, J; Jensen, JU; Johansen, ME; Larsen, KM; Lauritsen, AØ; Lundgren, B; Lundgren, JD; Løken, J; Mohr, T; Møller, JK; Olesen, B; Petersen, JA; Reinholdt, K; Strange, D; Søe-Jensen, P; Thormar, K; Tousi, H; Østergaard, C	1
Han, XY; Li, L; Tarrand, JJ	1
Du, Y; Guo, W; He, J; He, Q; Wang, Z; Wei, M; Wu, C; Yang, Z	1
Bhattacharya, S; Bhaumik, J; Chandy, M; Goel, G; Mukherjee, S	1
Bartoletti, R; Bjerklund Johansen, TE; Brugnolli, A; Cai, T; Eccher, C; Lanzafame, P; Luciani, LG; Malossini, G; Mirone, V; Pickard, R; Tiscione, D; Verze, P; Wagenlehner, FM	1
Amornchai, P; Day, NPJ; Langla, S; Limmathurotsakul, D; Peacock, SJ; White, NJ; Wuthiekanun, V	1
Alauzet, C; Benayad, H; Bertaux, A; Claudon, M; Lemarié, C; Malikov, S; Mandry, D; Risse, J; Settembre, N; Wahl, D; Zuily, S	1
Badal, RE; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S	1
Gholipourmalekabadi, M; Hashemi, A; Mozafari, M; Rostami, A; Sameni, M; Zamani, F	1
Ambeba, EJ; Cooper, JN; Deans, KJ; Lodwick, DL; Mahida, JB; Minneci, PC; Moss, RL; Nacion, KM; Sulkowski, JP	1
Chen, Y; Gao, W; Li, X; Ouyang, W; Wei, J; Wen, Z; Xue, H	1
Banerjee, R; Boyce, TG; Cunningham, SA; Hasassri, ME; Jeraldo, PR; Kaye, KS; Norgan, AP; Patel, R; Pogue, JM; Weissman, SJ	1
Abdel-Haq, N; Ang, JY; Nicolau, DP; Satlin, MJ; Thabit, AK; van Duin, D; Zhu, F	1
Cho, H; Eun Kim, D; Hee Park, S; Ho Jang, C; Huang, X; Jeong Yoon, E; Lan Piao, Y; Lee, K; Yeon Lee, S; Zhan, CG	1
Carvalheira, A; Casquete, R; Silva, J; Teixeira, P	1
Lipsky, BA; Mutluoglu, M	1
Anupurba, S; Banerjee, T	1
Ashraf, T; Darwish, D; Ghazawi, A; Mohsin, J; Pál, T; Petersen, JE; Sonnevend, A	1
Goodlet, KJ; Nailor, MD; Nicolau, DP	1
Heather, CS; Maley, M	1
Choi, JK; Joo, EJ; Ko, JH; Lee, NR; Moon, SY; Park, DA; Peck, KR	1
Bischoff, S; Ebert, M; Gerigk, M; Vogelmann, R; Walter, T	1

Trials

9 trial(s) available for ciprofloxacin and penicillanic acid

Article	Year
Neutropenic infections: a review of the French Febrile Aplasia Study Group trials in 608 febrile neutropenic patients. The Journal of antimicrobial chemotherapy, 1998, Volume: 41 Suppl D Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Fever; Hematologic Neoplasms; Humans; Multivariate Analysis; Neutropenia; Opportunistic Infections; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin	1998
Pharmacodynamic interactions of ciprofloxacin, piperacillin, and piperacillin/tazobactam in healthy volunteers. Journal of clinical pharmacology, 1998, Volume: 38, Issue:11 Topics: Adolescent; Adult; Anti-Infective Agents; Area Under Curve; Ciprofloxacin; Cross-Over Studies; Drug Interactions; Enzyme Inhibitors; Female; Humans; Male; Metabolic Clearance Rate; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam	1998
Comparison of intravenous/oral ciprofloxacin plus metronidazole versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections. Annals of surgery, 2000, Volume: 232, Issue:2 Topics: Abdomen; Abdominal Abscess; Administration, Oral; Anti-Infective Agents; Appendicitis; Bacterial Infections; Ciprofloxacin; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Male; Metronidazole; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies	2000
Antimicrobial prophylaxis for transrectal prostatic biopsy: a prospective study of ciprofloxacin vs piperacillin/tazobactam. BJU international, 2002, Volume: 90, Issue:7 Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Bacterial Infections; Biopsy; Ciprofloxacin; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Injections, Intramuscular; Male; Penicillanic Acid; Penicillins; Piperacillin; Postoperative Complications; Prospective Studies; Prostatic Diseases; Tazobactam; Transurethral Resection of Prostate	2002
Piperacillin-tazobactam versus ciprofloxacin plus amoxicillin in the treatment of infective episodes after liver transplantation. The Journal of antimicrobial chemotherapy, 2003, Volume: 52, Issue:6 Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Double-Blind Method; Drug Therapy, Combination; Enterobacteriaceae; Female; Fever; Humans; Liver Transplantation; Male; Metronidazole; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Piperacillin, Tazobactam Drug Combination; Postoperative Complications; Prospective Studies; Staphylococcus aureus	2003
Pharmacoeconomics of ciprofloxacin plus metronidazole vs. piperacillin-tazobactam for complicated intra-abdominal infections. Surgical infections, 2008, Volume: 9, Issue:3 Topics: Abdominal Abscess; Adult; Aged; Anti-Bacterial Agents; Appendicitis; Ciprofloxacin; Cost-Benefit Analysis; Double-Blind Method; Drug Therapy, Combination; Economics, Pharmaceutical; Female; Humans; Male; Metronidazole; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Treatment Outcome	2008
[Perioperative antibiotic prophylaxis in radical retropubic prostatectomy: a randomised pilot study of perioperative and postoperative administration]. Aktuelle Urologie, 2011, Volume: 42, Issue:1 Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Body Temperature; C-Reactive Protein; Ciprofloxacin; Drug Administration Schedule; Drug Therapy, Combination; Humans; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Neoplasm Staging; Penicillanic Acid; Perioperative Care; Pilot Projects; Piperacillin; Postoperative Complications; Prostatectomy; Prostatic Neoplasms; Retrospective Studies; Surgical Wound Infection; Tazobactam; Trimethoprim, Sulfamethoxazole Drug Combination	2011
Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneity. PloS one, 2013, Volume: 8, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Cefepime; Cephalosporins; Ciprofloxacin; Drug Administration Schedule; Female; Fever; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Male; Meropenem; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Thienamycins	2013
Invasive Candida infections and the harm from antibacterial drugs in critically ill patients: data from a randomized, controlled trial to determine the role of ciprofloxacin, piperacillin-tazobactam, meropenem, and cefuroxime. Critical care medicine, 2015, Volume: 43, Issue:3 Topics: Age Factors; Aged; Anti-Bacterial Agents; APACHE; Candidiasis, Invasive; Cefuroxime; Ciprofloxacin; Critical Illness; Denmark; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Intensive Care Units; Male; Meropenem; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Single-Blind Method; Thienamycins	2015

Other Studies

74 other study(ies) available for ciprofloxacin and penicillanic acid

Article	Year
In vitro activity of various antimicrobial agents against Staphylococcus aureus isolates including fluoroquinolone- and oxacillin-resistant strains. Diagnostic microbiology and infectious disease, 1992, Volume: 15, Issue:6 Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Microbial Sensitivity Tests; Oxacillin; Penicillanic Acid; Staphylococcus aureus; Tazobactam	1992
The in-vitro activity of piperacillin/tazobactam, ciprofloxacin, ceftazidime and imipenem against multiple resistant gram-negative bacteria. The Journal of antimicrobial chemotherapy, 1990, Volume: 25, Issue:6 Topics: Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Citrobacter; Drug Resistance, Microbial; Enterobacteriaceae; Gram-Negative Bacteria; Imipenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Serratia; Tazobactam	1990
In vitro pharmacodynamics of piperacillin, piperacillin-tazobactam, and ciprofloxacin alone and in combination against Staphylococcus aureus, Klebsiella pneumoniae, Enterobacter cloacae, and Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:8 Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Drug Therapy, Combination; Enterobacter cloacae; Enzyme Inhibitors; Klebsiella pneumoniae; Least-Squares Analysis; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Tazobactam; Time Factors	1995
Multicenter evaluation of the in vitro activity of piperacillin-tazobactam compared with eleven selected beta-lactam antibiotics and ciprofloxacin against more than 42,000 aerobic gram-positive and gram-negative bacteria. In Vitro Susceptibility Surveilla Diagnostic microbiology and infectious disease, 1994, Volume: 19, Issue:2 Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Ciprofloxacin; Gram-Negative Bacteria; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam	1994
Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes. Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:10 Topics: Anti-Infective Agents; Bacteria, Anaerobic; Cefoxitin; Ciprofloxacin; Fluoroquinolones; Metronidazole; Microbial Sensitivity Tests; Naphthyridines; Penicillanic Acid; Piperacillin; Piperazines; Quinolones; Tazobactam	1994
In vitro susceptibility of 124 Xanthomonas maltophilia (Stenotrophomonas maltophilia) isolates: comparison of the agar dilution method with the E-test and two agar diffusion methods. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 1996, Volume: 104, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Ceftazidime; Ciprofloxacin; Enzyme Inhibitors; Escherichia coli; Gentamicins; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Tazobactam; Trimethoprim, Sulfamethoxazole Drug Combination; Xanthomonas	1996
A new time-kill method of assessing the relative efficacy of antimicrobial agents alone and in combination developed using a representative beta-lactam, aminoglycoside and fluoroquinolone. The Journal of antimicrobial chemotherapy, 1996, Volume: 38, Issue:2 Topics: Acinetobacter; Ciprofloxacin; Citrobacter freundii; Drug Therapy, Combination; Enterobacteriaceae; Gentamicins; Microbial Sensitivity Tests; Models, Biological; Penicillanic Acid; Piperacillin; Serratia marcescens; Tazobactam	1996
Timed killing kinetic studies of the interaction between ciprofloxacin and beta-lactams against gram-negative bacilli. Diagnostic microbiology and infectious disease, 1996, Volume: 26, Issue:1 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Ceftazidime; Cephalosporins; Ciprofloxacin; Clavulanic Acid; Clavulanic Acids; Drug Interactions; Drug Therapy, Combination; Enterobacter cloacae; Enzyme Inhibitors; Kinetics; Klebsiella pneumoniae; Microbial Sensitivity Tests; Monobactams; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas aeruginosa; Serratia marcescens; Tazobactam; Ticarcillin; Time Factors	1996
In-vitro pharmacodynamic studies of piperacillin/tazobactam with gentamicin and ciprofloxacin. The Journal of antimicrobial chemotherapy, 1997, Volume: 39, Issue:1 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; beta-Lactamase Inhibitors; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Gentamicins; Kinetics; Macrolides; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam	1997
Time-kill study of the activity of trovafloxacin compared with ciprofloxacin, sparfloxacin, metronidazole, cefoxitin, piperacillin and piperacillin/tazobactam against six anaerobes. The Journal of antimicrobial chemotherapy, 1997, Volume: 39 Suppl B Topics: Anti-Infective Agents; Bacteroides; Bacteroides fragilis; Cefoxitin; Ciprofloxacin; Clostridium perfringens; Fluoroquinolones; Fusobacterium; Gram-Negative Anaerobic Bacteria; Metronidazole; Microbial Sensitivity Tests; Naphthyridines; Penicillanic Acid; Peptostreptococcus; Piperacillin; Prevotella melaninogenica; Quinolones; Tazobactam	1997
Effect of pH on in vitro antimicrobial susceptibility of the Bacteroides fragilis group. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:9 Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteroides fragilis; Ciprofloxacin; Clindamycin; Drug Therapy, Combination; Fluoroquinolones; Hydrogen-Ion Concentration; Imipenem; Meropenem; Microbial Sensitivity Tests; Naphthyridines; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Thienamycins	1997
Comparative in vitro evaluation of piperacillin/tazobactam in a tertiary care hospital. Journal of chemotherapy (Florence, Italy), 1997, Volume: 9, Issue:5 Topics: Amoxicillin; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Ciprofloxacin; Clavulanic Acid; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Intensive Care Units; Microbial Sensitivity Tests; Penicillanic Acid; Penicillin Resistance; Penicillins; Piperacillin; Tazobactam	1997
Piperacillin/tazobactam in the treatment of Klebsiella pneumoniae infections in neonates. American journal of perinatology, 1998, Volume: 15, Issue:1 Topics: Anti-Infective Agents; beta-Lactamase Inhibitors; Cilastatin; Ciprofloxacin; Cross Infection; Drug Combinations; Drug Resistance, Microbial; Drug Resistance, Multiple; Enzyme Inhibitors; Female; Humans; Imipenem; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Protease Inhibitors; Retrospective Studies; Tazobactam; Thienamycins	1998
Carbapenemase-producing Pseudomonas aeruginosa in UK. Lancet (London, England), 1998, Aug-15, Volume: 352, Issue:9127 Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Ciprofloxacin; Drug Resistance, Microbial; Enzyme Inhibitors; Gentamicins; Humans; Imipenem; Meropenem; Metalloproteins; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Thienamycins; United Kingdom	1998
Activity of piperacillin/tazobactam in combination with amikacin, ciprofloxacin, and trovafloxacin against Pseudomonas aeruginosa by time-kill. Diagnostic microbiology and infectious disease, 2000, Volume: 38, Issue:1 Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Chi-Square Distribution; Ciprofloxacin; Colony Count, Microbial; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Fluoroquinolones; Humans; Naphthyridines; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2000
Treatment of pulmonary nocardiosis in heart-transplant patients: importance of susceptibility studies. Clinical transplantation, 2001, Volume: 15, Issue:6 Topics: Adult; Anti-Bacterial Agents; Bronchoalveolar Lavage; Ciprofloxacin; Female; Heart Transplantation; Humans; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Nocardia; Nocardia Infections; Penicillanic Acid; Piperacillin; Postoperative Complications; Tazobactam; Trimethoprim, Sulfamethoxazole Drug Combination	2001
Emerging antimicrobial resistances among Proteus mirabilis in Europe: report from the MYSTIC Program (1997-2001). Meropenem Yearly Susceptibility Test Information Collection. Journal of chemotherapy (Florence, Italy), 2002, Volume: 14, Issue:3 Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Critical Care; Cystic Fibrosis; Data Collection; Drug Resistance, Bacterial; Europe; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Neutropenia; Penicillanic Acid; Piperacillin; Population Surveillance; Proteus Infections; Proteus mirabilis; Tazobactam; Thienamycins	2002
Selection of oxacillin resistance in oxacillin-sensitive Staphylococcus aureus through exposure to ciprofloxacin but not piperacillin/tazobactam. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2002, Volume: 21, Issue:8 Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Microbial Sensitivity Tests; Oxacillin; Penicillanic Acid; Penicillins; Piperacillin; Piperacillin, Tazobactam Drug Combination; Selection, Genetic; Staphylococcus aureus	2002
Cefepime, piperacillin/tazobactam, gentamicin, ciprofloxacin, and levofloxacin alone and in combination against Pseudomonas aeruginosa. Diagnostic microbiology and infectious disease, 2002, Volume: 44, Issue:1 Topics: Cefepime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Gentamicins; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Sensitivity and Specificity; Tazobactam	2002
Thrombocytosis under ciprofloxacin and tazobactam/piperacillin. Platelets, 2003, Volume: 14, Issue:5 Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Therapy, Combination; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Platelet Count; Pneumonia, Bacterial; Tazobactam; Thrombocytosis	2003
Stable antimicrobial susceptibility rates for clinical isolates of Pseudomonas aeruginosa from the 2001-2003 tracking resistance in the United States today surveillance studies. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Feb-15, Volume: 40 Suppl 2 Topics: beta-Lactams; Ceftazidime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gatifloxacin; Gentamicins; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; United States	2005
[Antibiotic susceptibility and occurrence of ESBL in Pseudomonas aeruginosa strains isolated from different clinical specimens]. Medycyna doswiadczalna i mikrobiologia, 2004, Volume: 56, Issue:3 Topics: Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Ceftazidime; Ciprofloxacin; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Thienamycins; Ticarcillin	2004
Antibacterial susceptibility of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli. The Israel Medical Association journal : IMAJ, 2005, Volume: 7, Issue:5 Topics: Adult; Amikacin; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Child; Ciprofloxacin; Clavulanic Acid; Drug Resistance, Bacterial; Enzyme Inhibitors; Escherichia coli; Humans; In Vitro Techniques; Israel; Klebsiella pneumoniae; Microbial Sensitivity Tests; Odds Ratio; Penicillanic Acid; Piperacillin; Prevalence; Tazobactam	2005
[Dynamic analysis of drug resistance of Pseudomonas aeruginosa in laboratory and clinical two-drug regimen]. Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA, 2005, Volume: 25, Issue:8 Topics: Amikacin; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Sulbactam; Tazobactam	2005
Pharmacodynamics of antimicrobials for the empirical treatment of nosocomial pneumonia: a report from the OPTAMA Program. Critical care medicine, 2005, Volume: 33, Issue:10 Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Cross Infection; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Thienamycins	2005
[Postoperative pneumonia: nosocomial, predictable, iatrogenic, preventable or not?]. Annales francaises d'anesthesie et de reanimation, 2006, Volume: 25, Issue:4 Topics: Alcoholism; Amoxicillin-Potassium Clavulanate Combination; Antibiotic Prophylaxis; Carcinoma, Squamous Cell; Ciprofloxacin; Cross Infection; Disease Susceptibility; Fatal Outcome; Humans; Iatrogenic Disease; Immunocompromised Host; Liver Cirrhosis, Alcoholic; Male; Malnutrition; Malpractice; Middle Aged; Mouth; Neck Dissection; Neoplasm Recurrence, Local; Oxygen; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Postoperative Complications; Pulmonary Disease, Chronic Obstructive; Risk Factors; Smoking; Tongue Neoplasms	2006
[Interstitial nephritis attributed to treatment with piperacillin-tazobactam and with ciprofloxacin]. Nederlands tijdschrift voor geneeskunde, 2006, Apr-08, Volume: 150, Issue:14 Topics: Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Humans; Male; Nephritis, Interstitial; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination	2006
[The combination effects of antibacterial agents against clinical isolated multiple-drug resistant Pseudomonas aeruginosa]. The Japanese journal of antibiotics, 2006, Volume: 59, Issue:1 Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefepime; Cefoperazone; Cephalosporins; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Humans; Meropenem; Microbial Sensitivity Tests; Oxazines; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Sulbactam; Tazobactam; Thienamycins	2006
Endocarditis caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: emergence of resistance to ciprofloxacin and piperacillin-tazobactam during treatment despite initial susceptibility. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:9 Topics: beta-Lactamases; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Endocarditis, Bacterial; Female; Heart Valve Prosthesis; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prosthesis-Related Infections; Thienamycins	2006
Implementation of antibiotic rotation protocol improves antibiotic susceptibility profile in a surgical intensive care unit. The Journal of trauma, 2007, Volume: 63, Issue:2 Topics: Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Clinical Protocols; Critical Care; Cross Infection; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Incidence; Intensive Care Units; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Probability; Retrospective Studies; Sensitivity and Specificity; Tazobactam; Treatment Outcome	2007
Comparison of the effect of ciprofloxacin and Tazocin on the incidence of meticillin-resistant Staphylococcus aureus (MRSA) in an Intensive Care Unit. International journal of antimicrobial agents, 2008, Volume: 32, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Ciprofloxacin; Cross Infection; Data Interpretation, Statistical; Drug Combinations; Electrophoresis, Gel, Pulsed-Field; Hand Disinfection; Hygiene; Intensive Care Units; Methicillin-Resistant Staphylococcus aureus; Penicillanic Acid; Personnel, Hospital; Piperacillin; Piperacillin, Tazobactam Drug Combination; Staphylococcal Infections; Tazobactam	2008
The use of piperacillin-tazobactam coated tympanostomy tubes against ciprofloxacin-resistant Pseudomonas biofilm formation: an in vitro study. International journal of pediatric otorhinolaryngology, 2009, Volume: 73, Issue:2 Topics: Anti-Bacterial Agents; Bacterial Adhesion; Bacteriological Techniques; Biofilms; Ciprofloxacin; Coated Materials, Biocompatible; Drug Resistance, Bacterial; Equipment Contamination; Equipment Design; Humans; Materials Testing; Microscopy, Electron, Scanning; Middle Ear Ventilation; Otitis Media, Suppurative; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prosthesis-Related Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Silicones; Surface Properties	2009
Health-related quality of life after intensive care unit discharge: A comparison between 2 standard antibiotic regimens. Infection control and hospital epidemiology, 2009, Volume: 30, Issue:8 Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Health Status; Humans; Intensive Care Units; Outcome Assessment, Health Care; Patient Discharge; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Quality of Life; Surveys and Questionnaires	2009
In-vitro efficacy of synergistic antibiotic combinations in multidrug resistant Pseudomonas aeruginosa strains. Yonsei medical journal, 2010, Volume: 51, Issue:1 Topics: Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Imipenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Tobramycin	2010
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase III as Topic; Doripenem; Enterobacteriaceae; Enterobacteriaceae Infections; Global Health; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prevalence	2010
Prior antimicrobial exposure and the risk for bloodstream infection with fluconazole-non-susceptible Candida strains. Scandinavian journal of infectious diseases, 2010, Volume: 42, Issue:6-7 Topics: Adult; Antifungal Agents; Candida; Candidiasis; Ciprofloxacin; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Logistic Models; Odds Ratio; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors	2010
Microbiologic and clinical implications of bacteremia due to extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae with or without plasmid-mediated AmpC beta-lactamase DHA-1. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Case-Control Studies; Ciprofloxacin; Female; Humans; Klebsiella pneumoniae; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Plasmids; Young Adult	2010
Impact of evaluating antibiotic concentrations in abdominal abscesses percutaneously drained. American journal of surgery, 2011, Volume: 201, Issue:3 Topics: Abdominal Abscess; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cephalosporins; Ciprofloxacin; Exudates and Transudates; Female; Fluconazole; Humans; Male; Metronidazole; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Suction; Treatment Outcome; Vancomycin	2011
Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units. The new microbiologica, 2011, Volume: 34, Issue:3 Topics: Amikacin; Anti-Bacterial Agents; Cefoperazone; Ceftazidime; Ciprofloxacin; Czech Republic; Drug Resistance, Multiple, Bacterial; Gentamicins; Intensive Care Units; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Sulbactam; Tazobactam	2011
Neonatal meningitis caused by Elizabethkingia meningoseptica in Saudi Arabia. Journal of infection in developing countries, 2011, Oct-13, Volume: 5, Issue:10 Topics: Anti-Bacterial Agents; Ciprofloxacin; Flavobacteriaceae; Flavobacteriaceae Infections; Humans; Infant, Newborn; Male; Meningitis, Bacterial; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Saudi Arabia; Treatment Outcome	2011
Meningitis and pneumonitis caused by pet rodents. The Medical journal of Australia, 2012, Feb-20, Volume: 196, Issue:3 Topics: Adult; Animals; Anti-Bacterial Agents; C-Reactive Protein; Ceftriaxone; Ciprofloxacin; Female; Fusobacterium Infections; Humans; Hypoxia; Meningitis, Bacterial; Penicillanic Acid; Pets; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Rats; Respiratory Distress Syndrome; Streptobacillus; Thrombocytopenia	2012
Comparative assessment of antimicrobial usage measures in the Department of Veterans Affairs. Infection control and hospital epidemiology, 2012, Volume: 33, Issue:4 Topics: Anti-Infective Agents; Ciprofloxacin; Drug Utilization Review; Hospitals, Veterans; Humans; Imipenem; Meropenem; Penicillanic Acid; Pilot Projects; Piperacillin; Piperacillin, Tazobactam Drug Combination; Thienamycins; United States; Vancomycin	2012
Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study. Critical care medicine, 2012, Volume: 40, Issue:5 Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Ciprofloxacin; Critical Illness; Female; Hemofiltration; Humans; Male; Meropenem; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam; Thienamycins; Vancomycin	2012
Antibiotics as first-line therapy for acute appendicitis: evidence for a change in clinical practice. World journal of surgery, 2012, Volume: 36, Issue:9 Topics: Acute Disease; Administration, Intravenous; Administration, Oral; Adult; Anti-Bacterial Agents; Appendicitis; Ciprofloxacin; Female; Humans; Male; Metronidazole; Penicillanic Acid; Piperacillin; Prospective Studies; Randomized Controlled Trials as Topic; Tazobactam	2012
Antibiotics as first-line therapy for acute appendicitis: evidence for a change in clinical practice. World journal of surgery, 2012, Volume: 36, Issue:9 Topics: Anti-Bacterial Agents; Appendicitis; Ciprofloxacin; Female; Humans; Male; Metronidazole; Penicillanic Acid; Piperacillin; Tazobactam	2012
Antibiotics as first-line therapy for acute appendicitis: evidence for a change in clinical practice. World journal of surgery, 2012, Volume: 36, Issue:12 Topics: Anti-Bacterial Agents; Appendicitis; Ciprofloxacin; Female; Humans; Male; Metronidazole; Penicillanic Acid; Piperacillin	2012
Antimicrobial susceptibility pattern and distribution of exoU and exoS in clinical isolates of Pseudomonas aeruginosa at a Malaysian hospital. The Southeast Asian journal of tropical medicine and public health, 2012, Volume: 43, Issue:1 Topics: ADP Ribose Transferases; Adult; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Cefepime; Ceftazidime; Cephalosporins; Chi-Square Distribution; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Gentamicins; Hospitals; Humans; Malaysia; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymerase Chain Reaction; Pseudomonas aeruginosa	2012
Mean (standard deviation) or mean (standard error of mean): time to ponder. World journal of surgery, 2013, Volume: 37, Issue:4 Topics: Anti-Bacterial Agents; Appendicitis; Ciprofloxacin; Female; Humans; Male; Metronidazole; Penicillanic Acid; Piperacillin	2013
Effects of infection control measures on acquisition of five antimicrobial drug-resistant microorganisms in a tetanus intensive care unit in Vietnam. Intensive care medicine, 2013, Volume: 39, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ceftazidime; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Microbial; Female; Gram-Negative Bacteria; Humans; Infant; Infant, Newborn; Infection Control; Intensive Care Units; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Tetanus; Vietnam; Young Adult	2013
Risk factors associated with preoperative fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in liver transplant recipients. Transplant infectious disease : an official journal of the Transplantation Society, 2014, Volume: 16, Issue:1 Topics: Adult; Amikacin; beta-Lactamases; beta-Lactams; Cefoxitin; Ciprofloxacin; Drug Resistance, Bacterial; End Stage Liver Disease; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Feces; Female; Humans; Imipenem; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Preoperative Period; Risk Factors; Severity of Illness Index	2014
Prevention of Clostridium difficile spore formation by sub-inhibitory concentrations of tigecycline and piperacillin/tazobactam. BMC infectious diseases, 2014, Jan-15, Volume: 14 Topics: Anti-Bacterial Agents; Ciprofloxacin; Clostridioides difficile; Humans; Metronidazole; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Ribotyping; Spores, Bacterial; Tazobactam; Tigecycline; Vancomycin	2014
Epidemic and virulence characteristic of Shigella spp. with extended-spectrum cephalosporin resistance in Xiaoshan District, Hangzhou, China. BMC infectious diseases, 2014, May-15, Volume: 14 Topics: Adolescent; Adult; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporin Resistance; Cephalosporins; Child; Child, Preschool; China; Ciprofloxacin; Dysentery, Bacillary; Female; Galanin; Genes, Bacterial; Genotype; Humans; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymerase Chain Reaction; Shigella; Substance P; Virulence	2014
Quantification of piperacillin, tazobactam, cefepime, meropenem, ciprofloxacin and linezolid in serum using an isotope dilution UHPLC-MS/MS method with semi-automated sample preparation. Clinical chemistry and laboratory medicine, 2015, Volume: 53, Issue:5 Topics: Analytic Sample Preparation Methods; Anti-Bacterial Agents; Automation; Blood Chemical Analysis; Cefepime; Cephalosporins; Chromatography, High Pressure Liquid; Ciprofloxacin; Humans; Isotopes; Linezolid; Meropenem; Penicillanic Acid; Piperacillin; Tandem Mass Spectrometry; Tazobactam; Thienamycins; Time Factors	2015
Microbiological and clinical features of four cases of catheter-related infection by Methylobacterium radiotolerans. Journal of clinical microbiology, 2015, Volume: 53, Issue:4 Topics: Aged, 80 and over; Anti-Bacterial Agents; Catheter-Related Infections; Child; Ciprofloxacin; Female; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Methylobacterium; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Young Adult	2015
Influence of antimicrobial consumption on gram-negative bacteria in inpatients receiving antimicrobial resistance therapy from 2008-2013 at a tertiary hospital in Shanghai, China. American journal of infection control, 2015, Apr-01, Volume: 43, Issue:4 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Ceftazidime; China; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Utilization Review; Escherichia coli; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Inpatients; Klebsiella pneumoniae; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Tertiary Care Centers	2015
Epidemiology of antimicrobial resistance in an oncology center in eastern India. Infection control and hospital epidemiology, 2015, Volume: 36, Issue:7 Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Cancer Care Facilities; Carbapenems; Ceftazidime; Ciprofloxacin; Clindamycin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Enterobacteriaceae; Feces; Fluconazole; Gentamicins; Humans; India; Methicillin-Resistant Staphylococcus aureus; Mycoses; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas; Yeasts	2015
Adherence to European Association of Urology Guidelines on Prophylactic Antibiotics: An Important Step in Antimicrobial Stewardship. European urology, 2016, Volume: 69, Issue:2 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Europe; Female; Gentamicins; Guideline Adherence; Humans; Klebsiella; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Guidelines as Topic; Trimethoprim, Sulfamethoxazole Drug Combination; Urologic Surgical Procedures; Urology	2016
Antimicrobial Disk Susceptibility Testing of Leptospira spp. Using Leptospira Vanaporn Wuthiekanun (LVW) Agar. The American journal of tropical medicine and hygiene, 2015, Volume: 93, Issue:2 Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Gentamicins; Leptospira; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Rifampin; Trimethoprim, Sulfamethoxazole Drug Combination	2015
Infected Abdominal Aortic Aneurysm Attributable to Haemophilus influenzae: Rapid Changes of Imaging Findings. Circulation, 2015, Aug-18, Volume: 132, Issue:7 Topics: Aneurysm, Infected; Anti-Bacterial Agents; Aortic Aneurysm, Abdominal; Aortography; Blood Vessel Prosthesis Implantation; C-Reactive Protein; Ciprofloxacin; Diagnostic Imaging; Haemophilus Infections; Haemophilus influenzae; Humans; Leukocyte Count; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Ribotyping; Tomography, X-Ray Computed	2015
Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1 Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; China; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Gene Expression; Humans; Imipenem; Intraabdominal Infections; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam	2016
Silver- and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: Activity against multidrug-resistant bacterial strains isolated from patients with burns. Burns : journal of the International Society for Burn Injuries, 2016, Volume: 42, Issue:1 Topics: Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Burns; Carbenicillin; Cefepime; Ceftazidime; Ceftriaxone; Cell Survival; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluorides; Gentamicins; Glass; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; NIH 3T3 Cells; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Silver; Thienamycins; Tobramycin; Wound Infection	2016
Effectiveness of Patient Choice in Nonoperative vs Surgical Management of Pediatric Uncomplicated Acute Appendicitis. JAMA surgery, 2016, 05-01, Volume: 151, Issue:5 Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Appendectomy; Appendicitis; Child; Ciprofloxacin; Family; Female; Health Care Costs; Humans; Laparoscopy; Male; Metronidazole; Patient Participation; Patient Preference; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Treatment Outcome	2016
Clinical characteristics and antimicrobial patterns in complicated intra-abdominal infections: a 6-year epidemiological study in southern China. International journal of antimicrobial agents, 2016, Volume: 47, Issue:3 Topics: Anti-Bacterial Agents; Carbapenems; China; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterococcus faecalis; Epidemiologic Studies; Escherichia coli; Female; Gentamicins; Humans; Intraabdominal Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Treatment Outcome	2016
An Immunocompromised Child with Bloodstream Infection Caused by Two Escherichia coli Strains, One Harboring NDM-5 and the Other Harboring OXA-48-Like Carbapenemase. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6 Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; beta-Lactams; Ciprofloxacin; Ertapenem; Escherichia coli; Female; Gentamicins; Humans; Immunocompromised Host; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam; Thienamycins; Tobramycin	2016
Multidrug-Resistant Pseudomonas aeruginosa Infection in a Child with Cystic Fibrosis. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:10 Topics: Adolescent; Amikacin; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Cystic Fibrosis; Drug Hypersensitivity; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2016
Molecular modeling and redesign of alginate lyase from Pseudomonas aeruginosa for accelerating CRPA biofilm degradation. Proteins, 2016, Volume: 84, Issue:12 Topics: Acetylation; Alginates; Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Biocatalysis; Biofilms; Ciprofloxacin; Cloning, Molecular; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Gene Expression; Glucuronic Acid; Hexuronic Acids; Hydrolysis; Kinetics; Molecular Dynamics Simulation; Mutation; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polysaccharide-Lyases; Protein Domains; Protein Engineering; Protein Structure, Secondary; Pseudomonas aeruginosa; Recombinant Proteins; Sequence Alignment; Structural Homology, Protein	2016
Prevalence and antimicrobial susceptibility of Acinetobacter spp. isolated from meat. International journal of food microbiology, 2017, Feb-21, Volume: 243 Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Animals; Anti-Bacterial Agents; Cattle; Ceftazidime; Chickens; Ciprofloxacin; Cross Infection; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prevalence; Red Meat; Sulbactam; Swine; Trimethoprim, Sulfamethoxazole Drug Combination	2017
Non-surgical treatment of diabetic foot osteomyelitis. The lancet. Diabetes & endocrinology, 2017, Volume: 5, Issue:8 Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Diabetes Mellitus, Type 2; Diabetic Foot; Humans; Male; Osteomyelitis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Treatment Outcome	2017
Risk factors associated with fluoroquinolone-resistant enterococcal urinary tract infections in a tertiary care university hospital in north India. The Indian journal of medical research, 2016, Volume: 144, Issue:4 Topics: Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Enterococcus; Female; Fluoroquinolones; Hospitals, University; Humans; India; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pregnancy; Risk Factors; Tertiary Care Centers; Urinary Tract Infections	2016
Plasmid-Mediated Colistin Resistance Gene mcr-1 in an Escherichia coli ST10 Bloodstream Isolate in the Sultanate of Oman. Microbial drug resistance (Larchmont, N.Y.), 2018, Volume: 24, Issue:3 Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Colistin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Gene Expression; Humans; Membrane Proteins; Microbial Sensitivity Tests; Oman; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Plasmids; Protein Isoforms; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination	2018
Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:12 Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Febrile Neutropenia; Humans; Iatrogenic Disease; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Practice Guidelines as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Tazobactam; Thienamycins; Tobramycin	2017
Automated direct screening for resistance of Gram-negative blood cultures using the BD Kiestra WorkCell. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2018, Volume: 37, Issue:1 Topics: Ampicillin; Anti-Bacterial Agents; Bacteremia; Blood Culture; Ceftriaxone; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Gentamicins; Gram-Negative Bacteria; Humans; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Thienamycins	2018
Appropriate non-carbapenems are not inferior to carbapenems as initial empirical therapy for bacteremia caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: a propensity score weighted multicenter cohort study. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2018, Volume: 37, Issue:2 Topics: Aged; Anti-Bacterial Agents; Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Ciprofloxacin; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Propensity Score; Retrospective Studies; Tertiary Care Centers; Thienamycins; Treatment Outcome	2018
Empiric antibiotic therapy in urinary tract infection in patients with risk factors for antibiotic resistance in a German emergency department. BMC infectious diseases, 2018, 01-26, Volume: 18, Issue:1 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Area Under Curve; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Emergency Service, Hospital; Female; Fluoroquinolones; Gentamicins; Germany; Humans; Male; Middle Aged; Odds Ratio; Penicillanic Acid; Piperacillin; Risk Factors; ROC Curve; Tazobactam; Urinary Tract Infections	2018